Cargando…
Risky behaviors and Parkinson disease: A mendelian randomization study
OBJECTIVE: To examine causal associations between risky behavior phenotypes and Parkinson disease using a mendelian randomization approach. METHODS: We used 2-sample mendelian randomization to generate unconfounded estimates using summary statistics from 2 independent, large meta-analyses of genome-...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010323/ https://www.ncbi.nlm.nih.gov/pubmed/31527283 http://dx.doi.org/10.1212/WNL.0000000000008245 |
Sumario: | OBJECTIVE: To examine causal associations between risky behavior phenotypes and Parkinson disease using a mendelian randomization approach. METHODS: We used 2-sample mendelian randomization to generate unconfounded estimates using summary statistics from 2 independent, large meta-analyses of genome-wide association studies on risk-taking behaviors (n = 370,771–939,908) and Parkinson disease (cases n = 9,581, controls n = 33,245). We used the inverse variance weighted method as the main method for judging causality. RESULTS: Our results support a strong protective association between the tendency to smoke and Parkinson disease (odds ratio [OR] 0.714 per log odds of ever smoking, 95% confidence interval [CI] 0.568–0.897, p = 0.0041, Cochran Q test p = 0.238; I(2) index 6.3%). Furthermore, we observed risk association trends between automobile speed propensity and the number of sexual partners and Parkinson disease after removal of overlapping loci with other risky traits (OR 1.986 for each 1-SD increase in normalized automobile speed propensity, 95% CI 1.215–3.243, p = 0.0066; OR 1.635 for each 1-SD increase in number of sexual partners, 95% CI 1.165–2.293, p = 0.0049). CONCLUSION: These findings provide support for a causal relationship between general risk tolerance and Parkinson disease and may provide new insights into the pathogenic mechanisms leading to the development of Parkinson disease. |
---|